FR2892022B1 - Traitement des symptomes de l'irritation de la vessie - Google Patents

Traitement des symptomes de l'irritation de la vessie

Info

Publication number
FR2892022B1
FR2892022B1 FR0510650A FR0510650A FR2892022B1 FR 2892022 B1 FR2892022 B1 FR 2892022B1 FR 0510650 A FR0510650 A FR 0510650A FR 0510650 A FR0510650 A FR 0510650A FR 2892022 B1 FR2892022 B1 FR 2892022B1
Authority
FR
France
Prior art keywords
symptoms
treatment
bladder irritation
irritation
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0510650A
Other languages
English (en)
Other versions
FR2892022A1 (fr
Inventor
Hugues Bienayme
Jacques Ferte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urogene SA
Original Assignee
Urogene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0510650A priority Critical patent/FR2892022B1/fr
Application filed by Urogene SA filed Critical Urogene SA
Priority to KR1020087010446A priority patent/KR20080058451A/ko
Priority to CNA2006800390097A priority patent/CN101291674A/zh
Priority to RU2008114395/14A priority patent/RU2008114395A/ru
Priority to US12/083,246 priority patent/US20080293774A1/en
Priority to CA002626573A priority patent/CA2626573A1/fr
Priority to AU2006305645A priority patent/AU2006305645A1/en
Priority to PCT/IB2006/003691 priority patent/WO2007046004A1/fr
Priority to EP06831761A priority patent/EP1948175A1/fr
Priority to JP2008536152A priority patent/JP2009512679A/ja
Priority to BRPI0617625-9A priority patent/BRPI0617625A2/pt
Publication of FR2892022A1 publication Critical patent/FR2892022A1/fr
Application granted granted Critical
Publication of FR2892022B1 publication Critical patent/FR2892022B1/fr
Priority to IL190800A priority patent/IL190800A0/en
Priority to ZA200803240A priority patent/ZA200803240B/xx
Priority to MA30903A priority patent/MA29934B1/fr
Priority to NO20082279A priority patent/NO20082279L/no
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0510650A 2005-10-19 2005-10-19 Traitement des symptomes de l'irritation de la vessie Expired - Fee Related FR2892022B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR0510650A FR2892022B1 (fr) 2005-10-19 2005-10-19 Traitement des symptomes de l'irritation de la vessie
BRPI0617625-9A BRPI0617625A2 (pt) 2005-10-19 2006-08-28 uso de composto
RU2008114395/14A RU2008114395A (ru) 2005-10-19 2006-08-28 Лечение симптомов раздражения мочевого пузыря
US12/083,246 US20080293774A1 (en) 2005-10-19 2006-08-28 Treatment of the Symptoms of Bladder Irritation
CA002626573A CA2626573A1 (fr) 2005-10-19 2006-08-28 Traitement des symptomes de l'irritation vesicale
AU2006305645A AU2006305645A1 (en) 2005-10-19 2006-08-28 Treatment of the symptoms of bladder irritation
PCT/IB2006/003691 WO2007046004A1 (fr) 2005-10-19 2006-08-28 Traitement des symptomes de l'irritation vesicale
EP06831761A EP1948175A1 (fr) 2005-10-19 2006-08-28 Traitement des symptomes de l'irritation vesicale
KR1020087010446A KR20080058451A (ko) 2005-10-19 2006-08-28 방광 자극 증상 치료
CNA2006800390097A CN101291674A (zh) 2005-10-19 2006-08-28 膀胱刺激症的治疗
JP2008536152A JP2009512679A (ja) 2005-10-19 2006-08-28 膀胱刺激症状の治療
IL190800A IL190800A0 (en) 2005-10-19 2008-04-10 Treatment of the symptoms of bladder irritation
ZA200803240A ZA200803240B (en) 2005-10-19 2008-04-11 Treatment of the symptoms of bladder irritation
MA30903A MA29934B1 (fr) 2005-10-19 2008-05-05 Traitement des symptomes de l'irritation vesicale
NO20082279A NO20082279L (no) 2005-10-19 2008-05-19 Behandling av blaereirritasjonssymptomer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0510650A FR2892022B1 (fr) 2005-10-19 2005-10-19 Traitement des symptomes de l'irritation de la vessie

Publications (2)

Publication Number Publication Date
FR2892022A1 FR2892022A1 (fr) 2007-04-20
FR2892022B1 true FR2892022B1 (fr) 2008-01-04

Family

ID=36579110

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0510650A Expired - Fee Related FR2892022B1 (fr) 2005-10-19 2005-10-19 Traitement des symptomes de l'irritation de la vessie

Country Status (15)

Country Link
US (1) US20080293774A1 (fr)
EP (1) EP1948175A1 (fr)
JP (1) JP2009512679A (fr)
KR (1) KR20080058451A (fr)
CN (1) CN101291674A (fr)
AU (1) AU2006305645A1 (fr)
BR (1) BRPI0617625A2 (fr)
CA (1) CA2626573A1 (fr)
FR (1) FR2892022B1 (fr)
IL (1) IL190800A0 (fr)
MA (1) MA29934B1 (fr)
NO (1) NO20082279L (fr)
RU (1) RU2008114395A (fr)
WO (1) WO2007046004A1 (fr)
ZA (1) ZA200803240B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions

Also Published As

Publication number Publication date
MA29934B1 (fr) 2008-11-03
BRPI0617625A2 (pt) 2011-08-02
KR20080058451A (ko) 2008-06-25
NO20082279L (no) 2008-05-19
ZA200803240B (en) 2009-01-28
AU2006305645A1 (en) 2007-04-26
RU2008114395A (ru) 2009-11-27
IL190800A0 (en) 2008-12-29
FR2892022A1 (fr) 2007-04-20
US20080293774A1 (en) 2008-11-27
CA2626573A1 (fr) 2007-04-26
WO2007046004A1 (fr) 2007-04-26
JP2009512679A (ja) 2009-03-26
EP1948175A1 (fr) 2008-07-30
CN101291674A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
FR20C1014I2 (fr) Traitement de troubles du cycle sommeil-eveil
ES2414872T8 (es) Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
SI2104682T1 (sl) Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602005027052D1 (de) Endoskopbehandlungssystem
FR2882654B1 (fr) Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques
ITPD20050266A1 (it) Apparato per il trattamento di patologie di origine malformativa e traumatica afferenti l'area del ginocchio
EP2001503A4 (fr) Diagnostic et traitement de la maladie d'alzheimer
FR2876047B1 (fr) Traitement de polluants par phytolixiviation
FR2883182B1 (fr) Composition de vitamines utiles dans le traitement des maladies oculaires
FR2897533B1 (fr) Agent oxydant pour le traitement des cheveux
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
MA28694B1 (fr) Traitement des infections bacteriennes
GB0526394D0 (en) Treatment of inflammatory diseases
FR2924593B1 (fr) Plaque osseuse pour le traitement de l'extremite inferieure du cubitus
FR2906469B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
EP1865952A4 (fr) Compositions contenant des histamines pour le traitement des allergies
FR2892022B1 (fr) Traitement des symptomes de l'irritation de la vessie
FR2898497B1 (fr) Utilisation de l'apratastat ou du (s)-n-hydroxy-4-(4-but-2- ynyloxy-benzenesulfonyl)-2,2-dimethyl-thiomorpholine-3-carbo xamide dans le traitement de pathologies inflammatoires cutanees
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
FR2906467B1 (fr) Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR2906466B1 (fr) Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR2884716B1 (fr) Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120629